TS-943

N/A

Report date: 2022/07/19 14:43:52
NME

Base Information

Drug NameTS-943
Drug Alias NameTS-943
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThrombosisCoronary Artery Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsThrombosisCoronary Artery Disease

Other Information

ATC CodeN/A
Related LinksN/A